Age and social-related risk factors for age-related macular degeneration among patients attending eye care at Jinja Regional Referral Hospital. A cross-sectional study.
DOI:
https://doi.org/10.51168/tg6cze81Keywords:
Macular Degeneration, Smoking, Irreversible blindness, Jinja Regional Referral HospitalAbstract
Background
Age-related macular degeneration causes irreversible blindness. There are two types of Age-related Macular Degeneration, that is to say, Wet macular degeneration and Dry macular degeneration. The study aims to assess aim of the study is to assess the Age and social-related Risk factors for age-related macular Degeneration.
Methodology
A Cross-sectional descriptive study design involving quantitative methods of data collection.
The study population comprised all patients receiving eye care services for Age-related Macular Degeneration conditions at the eye unit of Jinja Regional Referral Hospital for a period of 6 months from October 2022 to March 2023. Non-probability sampling was used to select 50 participants.
Results
The majority, 29/50 (58%) respondents were females, and 21/50 (42%) were males. 39/50 (78%) of the respondents lived in Rural areas, while a lower number, 11/50 (22%), lived in Urban areas. The majority, 25/50 (50%), were between 61-70 years, followed by respondents 14/50 (28%) who were between 51-60 years, followed by respondents 2/50 (4%) who were between 41-50 years, while the least were respondents 2/50 (4%). Most 24/50(48%) strongly agreed that smoking is a risk factor for age-related Macular Degeneration. 32/50 (64%) took alcohol, while18/50 (36%) did not take alcohol.
Conclusion
The significant risk factors for Age-related Macular Degeneration were increasing age groups of 61-70 years and 51-60 years, smoking, and a low level of education.
Recommendations
The Government should sensitize people on the risk factors for age-related Macular degeneration. At the same time, the Government should set up more eye clinics to increase accessibility to eye care services.
References
Armstrong RA and Mousavi M. (2015). Overview of Risk Factors for Age-Related Macular Degeneration (AMD). J Stem Cells 2015; 10(3):171-91. PMID: 27125062.
Bamini Gopinath. (2016, August 10). Health + Medicine. Retrieved from The Conversation Africa: https://theconversation.com/explainer-what-is-age-related-macular-degeneration-59889#:~:text=The%20main%20symptom%20of%20age-related%20macular%20degeneration%20is,blind%20spots%20in%20the%20centre%20of%20their%20vision.
Deng Y, Qiao L, Du M, Qu C, Wan L, Li J, Huang L. (2022). Age-related macular degeneration: epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy. Genes Dis. 2022, 9:62-79. 10.1016/j.gendis.2021.02.009 https://doi.org/10.1016/j.gendis.2021.02.009
F Ryan Prall, Andrew A Dahl. (2023, August 28). Drugs and Diseases >Ophthalmology. Retrieved from Medscape: https://emedicine.medscape.com/article/1226030-overview?form=fpf
Pennington KL and DeAngelis MM. (2016). Epidemiology of age-related macular degeneration (AMD): Associations with Cardiovascular disease Phenotypes and lipid factors.Eye Vis 2016:3:34 https://doi.org/10.1186/s40662-016-0063-5
Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. (2014). Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Global Health. 2014;2(2):e106-16. https://doi.org/10.1016/S2214-109X(13)70145-1
Xiayan Xu, Jing Wu, Xiaoning, Yu Yelei, Tang Xiajing, TangandXingchaoshentu (2020). Regional differences in the Global Burden of Age-Related Macular Degeneration. BMC Public Health Volume 20, 410(2020) http://doi.org/10.1186/s12889-020-8445-y
Ziyuan Wang, SriniVasR, Sadda, and Zhihong Hu. (2019). Deep learning for automated screening and semantic segmentation of age-related and Juvenile atrophic macular degeneration. Vol.10950 https://doi.org/10.1117/12.2511538
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Joshua Tumwebaze, Taddeo Mulumba (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.


